Pfizer, Cipla Pledge Better Access To Affordable Cancer Therapies In Africa
Pfizer and Cipla have separately committed to expanding access to affordable oncology drugs in sub-Saharan Africa in collaboration with the American Cancer Society and the Clinton Health Access Initiative. The public-private alliances are expected to enable procurement of these medicines for the African nations at significant savings, which Cipla tells Scrip could be in the region of 20-30% initially.
You may also be interested in...
Cipla's US business appears set to gain momentum with a string of differentiated generic launches lined up and the firm's CEO shares key insights into how price peaks and troughs could potentially play out in the world's largest pharmaceutical market.
Drug pricing has become the most contentious issue in the pharma world over the last two years as politics has dragged the subject into the mainstream conversation. Yet, even those within the industry have different ideas on how the problem can be fixed.
Firm supplying all-in-one multivitamin blends rather than packs of multiple pills has four-member advisory board including digital marketing and consumer product marketing specialists and a health care strategist.